Shares of Aura Biosciences AURA gained 7.9% on Sept. 12 after the company announced encouraging data from a phase II study ...

The most widely accepted theory is that nerve endings resting on the outer surface of the membranes that enclose the brain are responsible for the headaches that follow an aura. The new study ...

Organizational Decision Intelligence has just taken a massive leap forward. Aura Intelligence ("Aura"), the AI powerhouse ...

Aura’s inaugural Safety Day, called by “D Day” was held on October 10 and showcased the Company’s unwavering commitment to safety. The event began with an impactful video message from Aura ...

BOSTON - Aura Biosciences, Inc. (NASDAQ ... The new data stems from a study evaluating the safety and efficacy of bel-sar, a Virus-like-Drug-Conjugate (VDC), in patients with NMIBC.

SAN FRANCISCO, March 4, 2025 /PRNewswire/ -- Organizational Decision Intelligence has just taken a massive leap forward. Aura Intelligence ("Aura"), the AI powerhouse that turns fragmented ...

In the coming months, the Company will conduct a review of the feasibility study and evaluate alternatives to optimize scale, risk, and return profile of the project. Concurrently, Aura will ...